Study Evaluating the Efficacy and Safety of Three Formulations of Ultra-low Dose Estriol Vaginal Gel (0.005%, 0.002%, 0.0008% Estriol Vaginal Gel) for the Treatment of Vaginal Dryness in Postmenopausal Women With Vulvovaginal Atrophy
Condition: Vaginal Atrophy Interventions: Drug: Estriol; Drug: Placebo Sponsor: ITF Research Pharma, S.L.U. Recruiting - verified November 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 11, 2016 Category: Research Source Type: clinical trials
